STAT3 and metabolic disease: Our current results also show that hypercholesterolemia does not affect STAT3 phosphorylation after I/R with or without IPre, thereby providing a deeper insights into the rather unclear effects of metabolic disorders on cardiac STAT3 signaling [34].